Organigram Global (OGI) Shares Outstanding (Weighted Average) (2018 - 2026)
Organigram Global (OGI) reported Shares Outstanding (Weighted Average) of $673.9 million for Q1 2026, up 1.97% quarter-over-quarter from $660.9 million in Q4 2025.
Organigram Global (OGI) Shares Outstanding (Weighted Average) (2018 - 2026) Analysis & Trends
Organigram Global (OGI) has 9 years of Shares Outstanding (Weighted Average) data on file, last reported at $673.9 million in Q1 2026.
- Shares Outstanding (Weighted Average) for Q1 2026 came in at $673.9 million, changed N/A year-over-year; the trailing twelve-month figure through Mar 2026 was $673.9 million (changed N/A YoY), and the FY2025 annual result was $660.9 million, changed N/A from the prior year.
- Shares Outstanding (Weighted Average) improved to $673.9 million in Q1 2026 per OGI's latest filing, from $660.9 million in the prior quarter.
- Over five years, Shares Outstanding (Weighted Average) peaked at $673.9 million in Q1 2026 and troughed at $60.5 million in Q3 2023.
- A 5-year average of $458.3 million and a median of $643.0 million in 2024 frame the typical range for Shares Outstanding (Weighted Average).
- The sharpest annual moves came in 2022 and 2024: Shares Outstanding (Weighted Average) grew 1.38% in 2022, then jumped 932.71% in 2024.
- A 5-year view of Shares Outstanding (Weighted Average) shows it stood at $60.9 million in 2022, then declined by 0.62% to $60.5 million in 2023, then jumped by 932.71% to $625.2 million in 2024, then climbed by 5.7% to $660.9 million in 2025, then gained by 1.97% to $673.9 million in 2026.
- Business Quant data shows OGI's Shares Outstanding (Weighted Average) at $673.9 million in Q1 2026, $660.9 million in Q4 2025, and $668.4 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Shares (Weighted Avg.) (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 39.72 Bn | 35.98 Bn | 1.97 Bn | 1.16 Bn |
| 2 | Zoetis | 34.61 Bn | 32.67 Bn | 1.62 Bn | 422.10 Mn |
| 3 | United Therapeutics | 24.07 Bn | 21.91 Bn | 648.10 Mn | 43.50 Mn |
| 4 | Aurora Cannabis | 16.98 Bn | 16.91 Bn | 33.43 Mn | 5.02 Bn |
| 5 | Neurocrine Biosciences | 16.64 Bn | 15.32 Bn | 800.70 Mn | 100.50 Mn |
| 6 | Elanco Animal Health | 12.19 Bn | 11.76 Bn | 785.00 Mn | 497.70 Mn |
| 7 | Alkermes | 7.37 Bn | 6.86 Bn | -116.06 Mn | 166.20 Mn |
| 8 | Hims & Hers Health | 6.62 Bn | 5.87 Bn | 396.79 Mn | 228.36 Mn |
| 9 | Lantheus Holdings | 6.47 Bn | 5.97 Bn | 230.92 Mn | 64.74 Mn |
| 10 | Organigram Global | 731.20 Mn | 673.26 Mn | 11.96 Mn | 673.92 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 673.92 Mn |
| Dec 31, 2025 | 660.88 Mn |
| Sep 30, 2025 | 668.44 Mn |
| Sep 30, 2024 | 625.21 Mn |
| Sep 30, 2023 | 60.54 Mn |
| Aug 31, 2022 | 60.92 Mn |
| Nov 30, 2021 | 734.33 Mn |
| Aug 31, 2021 | 60.09 Mn |
| May 31, 2021 | 729.07 Mn |
| Feb 28, 2021 | 489.27 Mn |
| Nov 30, 2020 | 473.71 Mn |
| Aug 31, 2020 | 144.75 Mn |
| May 31, 2020 | 288.16 Mn |
| Feb 29, 2020 | 372.74 Mn |
| Nov 30, 2019 | 318.19 Mn |
| Aug 31, 2019 | 118.15 Mn |
| May 31, 2019 | 305.95 Mn |
| Aug 31, 2018 | 95.63 Mn |